Comparing exercise types for lowering blood pressure in young adults with hypertension
Compares aerobic, resistance and isometric exercise for blood pressure in young adults with hypertension.
Key facts
- Who runs it
- Northwestern University
- Where
- Chicago, United StatesSee the site
- Trial code
- Registry title
- A MOST Framework Trial Evaluating the MOst effectiVe Exercise Types for Blood Pressure Control
- Status
- Not yet recruiting
- People taking part
- 264 people, planned
- Starts
- 1 May 2027
- Expected to end
- Jan 2031
- Type of study
- Interventional, 8 groups
- Treatments tested
- Core intervention (Fitbit tracking and BP health education)
- Aerobic training (AT)
- Dynamic resistance training (DRT)
- Isometric resistance training (IRT)
- Record updated
- 6 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 44 with untreated stage I high blood pressure who are not very active. It tests which types of exercise lower blood pressure.
- Age
- 18 to 44 years
- Sex
- All sexes can join.
- Disease stage
- Untreated Stage I hypertension: blood pressure 130-139/80-89 mmHg, recorded at 2 or more outpatient visits in the past year. Average home blood pressure also 130-139/80-89 mmHg over 7 days.
- Earlier treatment
- No current blood pressure medicine. No GLP-1 receptor agonist use in the past year.
- Biomarker or test result
- Estimated 10-year cardiovascular disease risk below 7.5% by the PREVENT risk calculator. Body mass index 18.5 to 39.9 kg/m2.
Main reasons for not taking part
- Use of a GLP-1 receptor agonist in the past year
- Weight change of more than 15 lbs (7 kg) in the last 3 months
- Pregnant or planning pregnancy within 6 months
- Diabetes, chronic kidney disease, COPD, or heart and blood vessel disease
- Active cancer or current cancer treatment
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Age 18 to 44 years
- Northwestern University patient with untreated Stage I hypertension (blood pressure 130-139/80-89 mmHg) documented on at least 2 outpatient encounters in the prior year
- No current antihypertensive medication use
- Estimated 10-year cardiovascular disease risk below 7.5% by the PREVENT risk calculator
- Body mass index 18.5 to 39.9 kg/m2
- Average home blood pressure of 130-139/80-89 mmHg during a 7-day home monitoring period
- Fewer than 150 minutes per week of moderate-to-vigorous physical activity measured by accelerometer
- Exercise readiness confirmed by the Physical Activity Readiness Questionnaire for Everyone (PAR-Q+), with medical clearance if indicated
- English fluency
- Reliable internet access on a computer, smartphone, or tablet, with videoconference capability (e.g., Zoom)
Who cannot take part
- Weight change of more than 15 lbs in the prior 3 months
- Active cancer and/or currently receiving cancer treatment
- History of type 1 or type 2 diabetes
- History of chronic kidney disease
- History of chronic obstructive pulmonary disease
- History of cardiovascular disease or coronary heart disease
- Absolute contraindication to exercise (e.g., severe neurological, psychological, or orthopedic condition)
- Use of a glucagon-like peptide-1 receptor agonist (GLP-1 RA) within the past year
- Pregnant or planning to become pregnant within 6 months
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 44 years old?
Where in United States
- Northwestern UniversityChicago, United StatesContact: Mandy Pershing, MSNot yet recruiting
About the trial
What the trial wants to find out
Exercise is known to prevent nearly one in three cases of hypertension and slow its progression in young adults, but we do not know which specific exercise types are most effective. The main objective of this study is to determine which exercise prescription (ExRx) intervention component(s) alone or in combination most effectively lower systolic BP in young adults with stage I hypertension, identify the vascular mechanisms underlying these changes, and guide the development of optimized exercise-based prescription packages for effective hypertension control in this population.
The 8 groups in the trial
- Core + AT + DRT + IRTTreatment being tested
Participants receive the core intervention (Fitbit activity tracker and standard blood pressure health education) plus all three exercise components for 6 months: aerobic training (AT), dynamic resistance training (DRT), and isometric resistance training (IRT). AT: 4 sessions/week of moderate-to-vigorous endurance exercise, progressing from 40-59% to 60-89% heart rate reserve. DRT: 3 sessions/week of 6 exercises, 3 sets each, progressing from 50% to 70-80% of 1-repetition maximum. IRT: 3 sessions/week of a 3-exercise circuit, 4 sets of holds progressing to 2 minutes, at 30% maximum voluntary contraction (upper body) and 95% peak heart rate (lower body). Each component includes 1 trainer-supervised videoconference session per week; remaining sessions are unsupervised and guided by manualized videos.
Treatment: Core intervention (Fitbit tracking and BP health education), Aerobic training (AT), Dynamic resistance training (DRT), and Isometric resistance training (IRT)
- Core + AT + DRTTreatment being tested
Participants receive the core intervention (Fitbit activity tracker and standard blood pressure health education) plus aerobic training (AT) and dynamic resistance training (DRT) for 6 months. AT: 4 sessions/week of moderate-to-vigorous endurance exercise, progressing from 40-59% to 60-89% heart rate reserve. DRT: 3 sessions/week of 6 exercises, 3 sets each, progressing from 50% to 70-80% of 1-repetition maximum. Each component includes 1 trainer-supervised videoconference session per week; remaining sessions are unsupervised and guided by manualized videos.
Treatment: Core intervention (Fitbit tracking and BP health education), Aerobic training (AT), and Dynamic resistance training (DRT)
- Core + AT + IRTTreatment being tested
Participants receive the core intervention (Fitbit activity tracker and standard blood pressure health education) plus aerobic training (AT) and isometric resistance training (IRT) for 6 months. AT: 4 sessions/week of moderate-to-vigorous endurance exercise, progressing from 40-59% to 60-89% heart rate reserve. IRT: 3 sessions/week of a 3-exercise circuit, 4 sets of holds progressing to 2 minutes, at 30% maximum voluntary contraction (upper body) and 95% peak heart rate (lower body). Each component includes 1 trainer-supervised videoconference session per week; remaining sessions are unsupervised and guided by manualized videos.
Treatment: Core intervention (Fitbit tracking and BP health education), Aerobic training (AT), and Isometric resistance training (IRT)
- Core + ATTreatment being tested
Participants receive the core intervention (Fitbit activity tracker and standard blood pressure health education) plus aerobic training (AT) for 6 months. AT: 4 sessions/week of moderate-to-vigorous endurance exercise (e.g., walking, stair climbing), progressing from 40-59% to 60-89% heart rate reserve. Includes 1 trainer-supervised videoconference session per week; remaining sessions are unsupervised and guided by manualized videos.
Treatment: Core intervention (Fitbit tracking and BP health education) and Aerobic training (AT)
- Core + DRT + IRTTreatment being tested
Participants receive the core intervention (Fitbit activity tracker and standard blood pressure health education) plus dynamic resistance training (DRT) and isometric resistance training (IRT) for 6 months. DRT: 3 sessions/week of 6 exercises, 3 sets each, progressing from 50% to 70-80% of 1-repetition maximum. IRT: 3 sessions/week of a 3-exercise circuit, 4 sets of holds progressing to 2 minutes, at 30% maximum voluntary contraction (upper body) and 95% peak heart rate (lower body). Each component includes 1 trainer-supervised videoconference session per week; remaining sessions are unsupervised and guided by manualized videos.
Treatment: Core intervention (Fitbit tracking and BP health education), Dynamic resistance training (DRT), and Isometric resistance training (IRT)
- Core + DRTTreatment being tested
Participants receive the core intervention (Fitbit activity tracker and standard blood pressure health education) plus dynamic resistance training (DRT) for 6 months. DRT: 3 sessions/week of 6 exercises (e.g., squat, chest press, lunges, shoulder press), 3 sets each, progressing from 50% to 70-80% of 1-repetition maximum. Includes 1 trainer-supervised videoconference session per week; remaining sessions are unsupervised and guided by manualized videos.
Treatment: Core intervention (Fitbit tracking and BP health education) and Dynamic resistance training (DRT)
- Core + IRTTreatment being tested
Participants receive the core intervention (Fitbit activity tracker and standard blood pressure health education) plus isometric resistance training (IRT) for 6 months. IRT: 3 sessions/week of a 3-exercise circuit (e.g., wall sit, plank, glute bridge), 4 sets of holds progressing to 2 minutes, at 30% maximum voluntary contraction (upper body) and 95% peak heart rate (lower body). Includes 1 trainer-supervised videoconference session per week; remaining sessions are unsupervised and guided by manualized videos.
Treatment: Core intervention (Fitbit tracking and BP health education) and Isometric resistance training (IRT)
- Core onlyTreatment being tested
Participants receive the core intervention only for 6 months: a wrist-worn Fitbit activity tracker for daily wear and standard blood pressure health education materials (videos and flyers adapted from NHLBI and the American Heart Association) delivered twice per month. No exercise components are prescribed.
Treatment: Core intervention (Fitbit tracking and BP health education)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A MOST Framework Trial Evaluating the MOst effectiVe Exercise Types for Blood Pressure Control
- Plain-language title
- Comparing exercise types for lowering blood pressure in young adults with hypertensionGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07915752, who can take part
- Record updated
- 6 November 2026